European Healthtech startup funding raised during Q4 2016.
In Q4 2016, 89 European Healthtech companies raised a combined €420M across 92 funding rounds, down 26.4% versus Q4 2015. France led by capital raised, and Bpifrance was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| NaPopravku | Early VC | Nov 2016 | €46M |
| OxThera | Other | Oct 2016 | €32M |
| Atlas Genetics | Series D+ | Dec 2016 | €32M |
| Doctolib | Series C | Dec 2016 |
10 exits · €210M disclosed.
| Zur Rose | IPO | Dec 2016 | €184M |
| Genesort | Acquisition | Nov 2016 | €21M |
| dariohealth | IPO | Oct 2016 | €4.6M |
| €26M |
| NBE-Therapeutics | Series B | Oct 2016 | €19M |
| HealthWatch | Growth/Late | Dec 2016 | €18M |
| Corwave | Series B | Oct 2016 | €16M |
| Neuravi | Debt | Oct 2016 | €15M |
| Uromems | Series A | Oct 2016 | €12M |
| Univercells | Grant | Nov 2016 | €12M |
| QGel | Growth/Late | Nov 2016 | €11M |
| Owlstone Medical | Growth/Late | Dec 2016 | €11M |
| myTomorrows | Growth/Late | Dec 2016 | €10M |
| Ava | Series A | Oct 2016 | €8.8M |
| CellProthera | Early VC | Dec 2016 | €8.3M |
